Effect of supplementation with cobalamin carried either by a milk product or a capsule in mildly cobalamin-deficient elderly Dutch persons.

R. Dhonukshe-Rutten, M. van Zutphen, L. D. de Groot, S. Eussen, H. Blom, W. V. van Staveren
{"title":"Effect of supplementation with cobalamin carried either by a milk product or a capsule in mildly cobalamin-deficient elderly Dutch persons.","authors":"R. Dhonukshe-Rutten, M. van Zutphen, L. D. de Groot, S. Eussen, H. Blom, W. V. van Staveren","doi":"10.1093/AJCN/82.3.568","DOIUrl":null,"url":null,"abstract":"BACKGROUND\nA high prevalence of cobalamin deficiency occurs in the elderly population, which may be treated orally or with injections. Little is known about the relative bioavailability of crystalline cobalamin added to food products.\n\n\nOBJECTIVE\nThe objective was to assess the effect of supplementation with 1000 microg crystalline cobalamin, carried either by a milk product or a capsule, on cobalamin status in mildly cobalamin-deficient elderly Dutch persons.\n\n\nDESIGN\nTwo double-blind randomized controlled intervention studies, each covering a 12-wk supplementation period, were carried out in parallel. Mildly cobalamin-deficient elderly persons (n = 112) were separately recruited for the milk and capsule trials. Mild cobalamin deficiency was defined as a cobalamin concentration between 100 and 300 pmol/L and a plasma methylmalonic acid (MMA) concentration > or = 0.30 micromol/L. Allocation to the placebo or cobalamin carrier was carried out independently in both trials.\n\n\nRESULTS\nIn the fortified-milk group, the mean (+/-SD) increase in serum cobalamin was 250 +/- 96 pmol/L, the median (5th and 95th percentiles) decrease in plasma MMA was 0.19 (-0.76, -0.04) micromol/L, and the median decrease in plasma homocysteine was 4.0 (-7.3, 3.0) micromol/L. All changes were significantly different from those in the placebo milk group (P < 0.01). Likewise, in the cobalamin-capsule group, the mean increase in serum cobalamin was 281 +/- 136 pmol/L, the median decrease in plasma MMA was 0.18 (-2.95, 0.14) micromol/L, and the median decrease in plasma homocysteine was 1.8 (-10.6, 2.4) micromol/L; all changes were significantly different from those in the placebo capsule group (P < 0.01). No significant differences were observed between the fortified-milk and capsule groups (P > 0.40).\n\n\nCONCLUSION\nCrystalline cobalamin added to milk is an effective alternative to cobalamin capsules for improving cobalamin status.","PeriodicalId":315016,"journal":{"name":"The American journal of clinical nutrition","volume":"45 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2005-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"31","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The American journal of clinical nutrition","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/AJCN/82.3.568","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 31

Abstract

BACKGROUND A high prevalence of cobalamin deficiency occurs in the elderly population, which may be treated orally or with injections. Little is known about the relative bioavailability of crystalline cobalamin added to food products. OBJECTIVE The objective was to assess the effect of supplementation with 1000 microg crystalline cobalamin, carried either by a milk product or a capsule, on cobalamin status in mildly cobalamin-deficient elderly Dutch persons. DESIGN Two double-blind randomized controlled intervention studies, each covering a 12-wk supplementation period, were carried out in parallel. Mildly cobalamin-deficient elderly persons (n = 112) were separately recruited for the milk and capsule trials. Mild cobalamin deficiency was defined as a cobalamin concentration between 100 and 300 pmol/L and a plasma methylmalonic acid (MMA) concentration > or = 0.30 micromol/L. Allocation to the placebo or cobalamin carrier was carried out independently in both trials. RESULTS In the fortified-milk group, the mean (+/-SD) increase in serum cobalamin was 250 +/- 96 pmol/L, the median (5th and 95th percentiles) decrease in plasma MMA was 0.19 (-0.76, -0.04) micromol/L, and the median decrease in plasma homocysteine was 4.0 (-7.3, 3.0) micromol/L. All changes were significantly different from those in the placebo milk group (P < 0.01). Likewise, in the cobalamin-capsule group, the mean increase in serum cobalamin was 281 +/- 136 pmol/L, the median decrease in plasma MMA was 0.18 (-2.95, 0.14) micromol/L, and the median decrease in plasma homocysteine was 1.8 (-10.6, 2.4) micromol/L; all changes were significantly different from those in the placebo capsule group (P < 0.01). No significant differences were observed between the fortified-milk and capsule groups (P > 0.40). CONCLUSION Crystalline cobalamin added to milk is an effective alternative to cobalamin capsules for improving cobalamin status.
奶制品或胶囊对轻度钴胺缺乏的荷兰老年人补充钴胺素的影响。
背景:老年人群中钴胺素缺乏症发生率高,可口服或注射治疗。人们对添加到食品中的结晶钴胺素的相对生物利用度知之甚少。目的:目的是评估补充1000微晶体钴胺素(通过奶制品或胶囊携带)对轻度钴胺缺乏的荷兰老年人钴胺素状态的影响。设计并行进行两项双盲随机对照干预研究,每项研究涵盖12周的补充期。轻度钴胺缺乏的老年人(n = 112)分别被招募参加牛奶和胶囊试验。轻度钴胺素缺乏症定义为钴胺素浓度在100 - 300 pmol/L之间,血浆甲基丙二酸(MMA)浓度>或= 0.30微mol/L。在两项试验中,分别对安慰剂或钴胺素携带者进行分配。结果强化奶组血清钴胺素平均(+/- sd)升高250 +/- 96 pmol/L,血浆MMA中位数(第5和第95百分位数)降低0.19(-0.76,-0.04)微mol/L,血浆同型半胱氨酸中位数降低4.0(-7.3,3.0)微mol/L。与安慰剂组比较,差异均有统计学意义(P < 0.01)。同样,在钴胺素胶囊组中,血清钴胺素平均升高281 +/- 136 pmol/L,血浆MMA中位数降低0.18(-2.95,0.14)微mol/L,血浆同型半胱氨酸中位数降低1.8(-10.6,2.4)微mol/L;与安慰剂组比较差异均有统计学意义(P < 0.01)。强化乳组与胶囊组间差异不显著(P > 0.40)。结论乳中添加晶体钴胺素可有效替代钴胺素胶囊改善钴胺素状态。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信